✦ LIBER ✦

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

✍ Scribed by Thierry Gorlia; Martin J van den Bent; Monika E Hegi; René O Mirimanoff; Michael Weller; J Gregory Cairncross; Elizabeth Eisenhauer; Karl Belanger; Alba A Brandes; Anouk Allgeier; Denis Lacombe; Roger Stupp

Book ID: 118626439
Publisher: The Lancet
Year: 2008
Tongue: English
Weight: 231 KB
Volume: 9
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(07)70384-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality assurance of the EORTC 26981/229

Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review

✍ Fatma Ataman; Philip Poortmans; Roger Stupp; Barbara Fisher; René-Olivier Mirima 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Presence of an oligodendroglioma-like co

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial

✍ Monika E. Hegi, Robert-Charles Janzer, Wanyu L. Lambiv, Thierry Gorlia, Mathilde 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 829 KB

New prognostic factors and calculators f

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials

✍ Thierry Gorlia; Roger Stupp; Alba A. Brandes; Roy R. Rampling; Pierre Fumoleau; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 216 KB